Hormae Pharma

HORMÆ Pharma is a privately hold biotech company that was founded in November 2020 in Lyon, France. The founders are scientists, who have a strong record in immunology, virology and medicinal chemistry as well as experience in the creation and management of biopharmaceutical companies. The company is developing small molecule therapeutics targeting the cellular receptors that control the latency/replication balance of EBV to prevent and treat EBV induced pathologies. 

The company’s program results from the work initially conducted by the INSERM team of two co-founders at the International Centre for Research in Infectiology (CIRI). The library of proprietary receptors ligands was designed and synthetized by the third co-founder at Edelris.